Skip to main content
    H

    Health Catalyst Inc (HCAT)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.38
    -0.13 (-8.61%)

    Market Cap: $115.00M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Health Catalyst Inc (HCAT) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Health Catalyst (HCAT) to earn -$0.04 per share in the fiscal year ending Dec 31, 2026, on revenue of $247.87M. Of 5 analysts, 1 rates the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 4 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.80, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 20% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy120.0%
    Hold480.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    5

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates fall 18.7%.

    Fiscal year ending Dec 31, 2026
    -$0.04
    EPS consensus, revenue $247.87M
    Fiscal year ending Dec 31, 2027
    -$0.02
    EPS consensus, revenue $201.62M
    Next report
    Mar 10, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.04-$0.06 to -$0.033$247.87M$246.35M to $249.76M5
    Dec 31, 2027-$0.02-$0.12 to $0.104$201.62M$182.52M to $211.50M5

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.04-$0.05 to -$0.037$51.77M$48.96M to $54.81M7

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 1 upward and 7 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202604
    Fiscal year ending Dec 31, 202713

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.03.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.04-$0.04-$0.04-$0.05-$0.03N/A
    Fiscal year ending Dec 31, 2027-$0.02$0.01$0.01$0.01$0.06N/A

    Frequently Asked Questions About HCAT

    What is the HCAT stock forecast?

    Consensus analyst estimates put Health Catalyst's EPS at -$0.04 for the fiscal year ending Dec 31, 2026, on revenue of $247.87M. The consensus rating from 5 analysts is Hold.

    How do analysts rate HCAT stock?

    Of 5 analysts covering Health Catalyst, 0 rate it Strong Buy, 1 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from HCAT next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.04, with estimates from -$0.06 to -$0.03 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.02, with estimates from -$0.12 to $0.10 from 4 analysts.

    What revenue do analysts expect from Health Catalyst next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $247.87M, with estimates from $246.35M to $249.76M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $201.62M, with estimates from $182.52M to $211.50M.

    How many analysts cover HCAT?

    5 analysts rate Health Catalyst stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.